Remove 2022 Remove DEA Remove Programs Remove Topical
article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. 1, 2022), [link]. [14] 2] David E.

article thumbnail

Bill Clinton 1992 I Smoked Weed But Didn’t Inhale – 2022 I Said CBD Sounds Good But My Media Team Doesn’t Want To It To Be Public Knowledge

Cannabis Law Report

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.

Media 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA CBD Regulations Are On the Way (Sorta)

Canna Law Blog

To date, while taking input from the public on the topic, the FDA mostly has engaged in enforcement, sometimes in tandem with Federal Trade Commission (“FTC”), against CBD retailers. For years everyone has wondered when, or even if , the FDA would propose and adopt CBD regulations. The future of FDA CBD regulations.

CBD 75
article thumbnail

Colorado Could Legalize Psychedelics This November

Veriheal

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator.

article thumbnail

Canopy Growth Reports First Quarter Fiscal 2022 Financial Results – The John Bonham Of Cannabis?

Cannabis Law Report

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105
article thumbnail

Canopy Growth posts CA$1.7 billion annual loss

Cannabis Law Report

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping.

Data 95
article thumbnail

Memo to Congress: Fix the Farm Bill

Project CBD

23 Yet this conversion is occurring without regulatory oversight to ensure process standardization, product specification, and accurate third-party testing, all of which are mandated in state-licensed cannabis programs. 2022) [link] [link] [link] [link] [link] The post Memo to Congress: Fix the Farm Bill appeared first on Project CBD.